Funder: National Institutes of Health

Due Dates (Anticipated): November 2026 (Full application deadline, projected)

Funding Amounts: Estimated total program funding: $6,000,000; ~3 awards expected; award size/duration not specified.

Summary: Supports translational research to optimize and develop genomic and biologic therapeutic candidates for Alzheimer’s Disease-Related Dementias (ADRD).

Key Information: This is a forecasted opportunity; applications are not yet being solicited.